Rare diseases
Investigational molecules
Locations
Back to Germany689 clinical trials in Bad Krozingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
GermanyStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
GermanyStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
GermanyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
GermanyStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
GermanyStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
GermanyStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
GermanyStudy on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
GermanyStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
GermanyStudy of Tersolisib and a drug combination for adults with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
GermanyEfficacy and Safety of Three Different Doses of Pirtobrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Previously Received BTK Inhibitor Treatment
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lipoprotein management and preventive therapies for cardiovascular disease, exploring new treatments to reduce major cardiovascular events in high-risk patients.
Advanced studies evaluating novel therapeutic approaches for better cardiovascular outcomes.
Clinical investigations into deep vein thrombosis treatments and prevention of systemic embolism, particularly in patients with atrial fibrillation.
Comprehensive research on blood clot prevention and treatment methodologies.
Studies addressing hypertension management and innovative treatments for acute coronary syndromes, including specialized interventions for heart attack prevention.
Evaluating cutting-edge therapies for various cardiac conditions.
Research focusing on peripheral arterial disease and advanced vascular interventions, including novel contrast medium strategies for better patient outcomes.
Developing safer and more effective vascular treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
